Answers are grounded in this paper and cite their sources.
Observational analysis shows foreign ownership and R&D intensity influence financial performance in pharmaceutical firms, indicating the need for strategic disclosure.
This research aims to examine and analyse the role of foreign ownership on financial business performance with R&D intensity and intelectual capital disclosure as intervening variables. The research sample was pharmaceutical firms that listing in Indonesia Stock Exchange in 2019-2022; 9 pharmaceutical firms that accomplish the requirements of this research. Data were analysed by using the Structural Equation Modelling/SEM method with SmartPLS program. This research found that intelectual capital disclosure, R&D intensity had a positive effect on ROE. Foreign ownership has no effect on ROE. R&D intensity and foreign ownership have a positive effect on intelectual capital disclosure, foreign ownership has a positive effect on R&D intensity. The limitations of the research are time constraints and single sector studies. In the future, other industries may examine the role of foreign ownership, R&D intensity, and disclosure of intellectual capital on their financial business performance.
No takes yet. Share an insight, caveat, or question.
Bunyamin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: